| Year |
Citation |
Score |
| 2014 |
Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, Desai K, Gerdes MJ, Solnica-Krezel L, Coffey RJ. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer Journal of Clinical Investigation. 124: 2172-2187. PMID 24691442 DOI: 10.1172/Jci71103 |
0.335 |
|
| 2013 |
Wang Y, Poulin EJ, Coffey RJ. LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. British Journal of Cancer. 108: 1765-1770. PMID 23558895 DOI: 10.1038/Bjc.2013.138 |
0.304 |
|
| 2011 |
Wang Y, Powell AE, Li Y, Davenport JR, Franklin J, Haigis KM, Coffey RJ. Abstract 5188: Lrig1, a cell surface negative regulator of ErbB1-4, marks both proliferative and quiescent intestinal stem cells and acts as a tumor suppressor Cancer Research. 71: 5188-5188. DOI: 10.1158/1538-7445.Am2011-5188 |
0.338 |
|
| 2011 |
Powell A, Li Y, Wang Y, Franklin J, Haigis K, Coffey RJ. Lrig1 Marks a Distinct Population of Proliferative and Quiescent Intestinal Stem Cells and Acts as a Tumor Suppressor Gastroenterology. 140: S-39. DOI: 10.1016/S0016-5085(11)60153-4 |
0.319 |
|
| 2010 |
Wang Y, Coffey RJ, Osheroff N, Neufeld KL. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy. Plos One. 5: e9994. PMID 20368985 DOI: 10.1371/Journal.Pone.0009994 |
0.639 |
|
| 2009 |
Wang Y, Azuma Y, Friedman DB, Coffey RJ, Neufeld KL. Novel association of APC with intermediate filaments identified using a new versatile APC antibody. Bmc Cell Biology. 10: 75. PMID 19845967 DOI: 10.1186/1471-2121-10-75 |
0.621 |
|
| 2008 |
Wang Y, Azuma Y, Moore D, Osheroff N, Neufeld KL. Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition. Molecular Biology of the Cell. 19: 4076-85. PMID 18632987 DOI: 10.1091/Mbc.E07-12-1296 |
0.633 |
|
| Show low-probability matches. |